Aalberse Rob C
Sanquin Research at CLB and Karl Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Chem Immunol Allergy. 2006;91:134-46. doi: 10.1159/000090277.
In this paper the relation between protein allergenicity (the capacity to induce IgE antibody production or the capacity to activate mast cells sensitized with IgE antibodies induced by a cross-reactive allergen) and protein structure is discussed. While cross-reactivity is to a large degree predictable from primary sequence comparisons, the IgE-inducing capacity is mostly determined by factors other than the primary sequence. Two routes to IgE are discussed: (1) the atopic route (used by allergens from pollen and mites) in which a direct switch from mu to epsilon is common and (2) the 'modified Th2' route (used by allergens from pets) in which the class switch to IgE is often preceded by a switch to IgG4. According to this working hypothesis, the choice between these two routes is determined at the level of the germinal center activity.
本文讨论了蛋白质变应原性(诱导IgE抗体产生的能力或激活由交叉反应性变应原诱导产生的IgE抗体致敏的肥大细胞的能力)与蛋白质结构之间的关系。虽然交叉反应性在很大程度上可通过一级序列比较预测,但诱导IgE的能力主要由一级序列以外的因素决定。文中讨论了两条产生IgE的途径:(1)特应性途径(花粉和螨类变应原所采用),其中从μ链直接转换为ε链很常见;(2)“改良Th2”途径(宠物变应原所采用),其中向IgE的类别转换通常先于向IgG4的转换。根据这一工作假说,这两条途径之间的选择在生发中心活动水平上确定。